NOWDiagnostics Wins De Novo For First OTC Syphilis Test
Executive Summary
The US FDA has granted marketing authorization to NOWDiagnostics for the first at-home over-the-counter test to detect syphilis, which the government says is on the rise.
Topics
- Subjects
- FDA
- OTC Devices
- Approvals
- Companies
- Policy
- Regulation
- Device Areas
- Diagnostics
- Gynecology & Urology
- Patient Monitoring
- Regions
- North America
- Therapy Areas
- Infectious Diseases
- Industries
- Medical Device
Latest Headlines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MT155048
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
MT155048
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.